previous page   Pak Vet J, xxxx, xx(x): xxx   next page
Protective Effect of Astaxanthin on Histopathologic Changes Induced by Bisphenol A in the Liver of Rats
Seda Cetinkaya Karabekir1*, Burcu Gultekin2, Ilknur Cınar Ayan3, Hasan Basri Savas4, Gokhan Cuce2 and Serpil Kalkan2

1Izmir Bakırcay University, Faculty of Medicine, Department of Histology and Embryology, Izmir, Turkey; 2Necmettin Erbakan University, Faculty of Medicine, Departments of Histology and Embryology, Meram, Konya, Turkey; 3Necmettin Erbakan University, Faculty of Medicine, Department of Medical Biology, Meram, Konya, Turkey; 4Mardin Artuklu University, Faculty of Medicine, Department of Medical Biochemistry, Mardin, Turkey
*Corresponding author:


Bisphenol A (BPA) has several potential uses, including in polycarbonate plastics and epoxy resins, which could expose humans to it. Recognized for its hepatotoxicity and ability to accumulate in organs. We prompted this study to explore the hepatoprotective potential of astaxanthin (ASTX), an antioxidant against BPA toxicity. We used 32 male Wistar Albino rats and randomly assigned them as: Control, Sham (olive oil), BPA, and BPA+ASTX. At the end of the experiment, Native Thiol, Total Thiol, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were measured in serum samples. Histopathological scoring was performed to evaluate the changes caused by ASTX in the liver. Caspase 3 and caspase 9 expression in liver tissues was demonstrated immunohistochemically and by PCR. Collagen I (COL1A1) and collagen III (COL3A1) mRNA levels were measured by PCR in the tissue samples. The BPA group showed elevated AST and ALT with decreased Thiol levels. ASTX administration reversed these changes as observed by reduced AST and ALT levels and increased Thiol levels. Histopathology indicated increased liver damage and fibrosis in the BPA group which were alleviated in the BPA+ASTX group. Gene expression analyses revealed upregulated COL1A1 and COL3A1 in BPA, which was downregulated with ASTX. Immunohistochemistry and PCR confirmed BPA-induced caspase 3 and caspase 9 expression, which were attenuated by ASTX. This study underscores ASTX's hepatoprotective efficacy against BPA-induced hepatotoxicity which ultimately attributed to its antioxidant and antiapoptotic properties. Consequently, ASTX emerges as a promising therapeutic agent for preventing and treating BPA-related liver diseases.

To Cite This Article: Karabekir SC, Gultekın B, Ayan IC, Savas HB, Cuce G and Kalkan S, 2024. Protective effect of astaxanthin on histopathologic changes induced by bisphenol a in the liver of rats. Pak Vet J.


ISSN 0253-8318 (Print)
ISSN 2074-7764 (Online)

SCImago Journal & Country Rank